Literature DB >> 12783977

Derivative chromosome 9 deletions in chronic myeloid leukaemia: interpretation of atypical D-FISH pattern.

T S K Wan1, S K Ma, W Y Au, L C Chan.   

Abstract

BACKGROUND/AIMS: New molecular cytogenetic techniques are increasingly applied as a routine investigative tool in haematological malignancies, both at diagnosis and subsequent monitoring. This report describes the interpretation of atypical signal patterns encountered using BCR-ABL dual colour dual fusion fluorescence in situ hybridisation (D-FISH) translocation probes in chronic myeloid leukaemia (CML).
METHODS: Interphase FISH experiments were carried out using BCR-ABL D-FISH probes in 46 patients with CML at diagnosis and during subsequent disease monitoring. Atypical hybridisation signal patterns were characterised by molecular cytogenetic techniques and correlated with conventional karyotyping.
RESULTS: Two patients showed atypical interphase D-FISH patterns with one orange, one green, and one fusion (1O1G1F) signal. The presence of BCR-ABL gene fusion was documented by a dual colour single fusion (S-FISH) probe. The submicroscopic deletion of the ABL-BCR fusion gene on the derivative chromosome 9 in these cases was subsequently characterised by metaphase FISH on relocated G banded metaphases.
CONCLUSIONS: Atypical interphase D-FISH patterns should not be interpreted in isolation and should be considered in conjunction with other cytogenetic or molecular genetic investigations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12783977      PMCID: PMC1769964          DOI: 10.1136/jcp.56.6.471

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  A multicenter investigation with D-FISH BCR/ABL1 probes.

Authors:  G Dewald; R Stallard; A Alsaadi; S Arnold; R Blough; T M Ceperich; B Rafael Elejalde; J Fink; J V Higgins; R R Higgins; G A Hoeltge; W T Hsu; E B Johnson; D Kronberger; D J McCorquodale; L F Meisner; M A Micale; L Oseth; J S Payne; S Schwartz; S Sheldon; A Sophian; P Storto; P Van Tuinen; G D Wenger; A Wiktor; L A Willis; J F Yung; J Zenger-Hain
Journal:  Cancer Genet Cytogenet       Date:  2000-01-15

2.  Cytogenetic biclonality in polycythemia vera: unusual and unrelated clones.

Authors:  T S Wan; S K Ma; M Y Ho; L C Chan; S F Yip; L G Wong; Y M Yeung
Journal:  Cancer Genet Cytogenet       Date:  2001-11

3.  FISH analysis for CML monitoring?

Authors:  M C Froncillo; L Maffei; M Cantonetti; G Del Poeta; R Lentini; A Bruno; M Masi; M Tribalto; S Amadori
Journal:  Ann Hematol       Date:  1996-09       Impact factor: 3.673

4.  Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia.

Authors:  G W Dewald; W A Wyatt; A L Juneau; R O Carlson; A R Zinsmeister; S M Jalal; J L Spurbeck; R T Silver
Journal:  Blood       Date:  1998-05-01       Impact factor: 22.113

5.  Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia.

Authors:  P B Sinclair; E P Nacheva; M Leversha; N Telford; J Chang; A Reid; A Bench; K Champion; B Huntly; A R Green
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

6.  Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instability.

Authors:  Brian J P Huntly; Anthony J Bench; Eric Delabesse; Alistair G Reid; Juan Li; Mike A Scott; Lynda Campbell; Jennie Byrne; Eleanor Pinto; Andre Brizard; Deitger Niedermeiser; Elizabeth P Nacheva; Francois Guilhot; Michael Deininger; Anthony R Green
Journal:  Blood       Date:  2002-06-15       Impact factor: 22.113

7.  Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia.

Authors:  B J Huntly; A G Reid; A J Bench; L J Campbell; N Telford; P Shepherd; J Szer; H M Prince; P Turner; C Grace; E P Nacheva; A R Green
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

8.  Frequent deletion of hSNF5/INI1, a component of the SWI/SNF complex, in chronic myeloid leukemia.

Authors:  F Grand; S Kulkarni; A Chase; J M Goldman; M Gordon; N C Cross
Journal:  Cancer Res       Date:  1999-08-15       Impact factor: 12.701

9.  The application of fluorescent in situ hybridization to detect Mbcr/abl fusion in variant Ph chromosomes in CML and ALL.

Authors:  G W Dewald; C R Schad; E R Christensen; A L Tiede; A R Zinsmeister; J L Spurbeck; S N Thibodeau; S M Jalal
Journal:  Cancer Genet Cytogenet       Date:  1993-11

10.  A special fluorescent in situ hybridization technique to study peripheral blood and assess the effectiveness of interferon therapy in chronic myeloid leukemia.

Authors:  I Buño; W A Wyatt; A R Zinsmeister; J Dietz-Band; R T Silver; G W Dewald
Journal:  Blood       Date:  1998-10-01       Impact factor: 22.113

  10 in total
  1 in total

1.  Molecular cytogenetic study of derivative chromosome 9 deletion in chronic myeloid leukemia patients.

Authors:  Ayda Bennour; Ines Ouahchi; Yosra Ben Youssef; Monia Zaier; Mohamed Adnéne Laatiri; Imed Harrabi; Balkis Meddeb; Moez Elloumi; Abderrahim Khelif; Ali Saad; Halima Sennana
Journal:  Med Oncol       Date:  2011-04-03       Impact factor: 3.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.